Camp4 Therapeutics (CAMP) Proxy filing summary

Voting matters and shareholder proposals

• Election of three Class II Directors for a three-year term ending at the 2029 annual meeting, with nominees Steven Holtzman, Murray Stewart, and Richard Young recommended for election.

• Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

• Approval of an amendment to the 2024 Equity Incentive Plan is proposed.

• Proxies are authorized to vote on other business that may arise during the meeting or any adjournment.

Board of directors and corporate governance

• Board recommends all director nominees for election to serve until the 2029 annual meeting.

Executive compensation and say-on-pay

• Amendment to the 2024 Equity Incentive Plan is up for shareholder approval.